A detailed history of Gamma Investing LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 907 shares of ADMA stock, worth $17,269. This represents 0.0% of its overall portfolio holdings.

Number of Shares
907
Previous 494 83.6%
Holding current value
$17,269
Previous $5.52 Million 228.28%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$11.21 - $20.03 $4,629 - $8,272
413 Added 83.6%
907 $18.1 Million
Q1 2024

Apr 05, 2024

BUY
$4.4 - $6.74 $1,518 - $2,325
345 Added 231.54%
494 $3.26 Million
Q4 2023

Feb 01, 2024

BUY
$3.08 - $4.52 $458 - $673
149 New
149 $773,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.74B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.